Clinical evidence for orphan medicinal products-a cause for concern?

por Picavet, Eline, Cassiman, David, Hollak, Carla E, Maertens, Johan A, Simoens, Steven
Publicado 2013

604. IL-17C as an early diagnostic biomarker for invasive fungal infection or just a marker of any infection in at-risk haematology patients

por Aerts, Robina, Ponce, Isis Ricano, Bruno, Mariolina, Mercier, Toine, Rosati, Diletta, Maertens, Johan A, Kumar, Vinod, Carvalho, Agostinho, Netea, Mihai, Hoenigl, Martin
Publicado 2023

870. Olorofim for the treatment of invasive mould infections in patients with limited or no treatment options: Comparison of interim results from a Phase 2B open-label study with o...

por Maertens, Johan A, Verweij, Paul E, Lanuza, Evan F, Harvey, Emma L, Dane, Aaron, Zinzi, Daniela, Rex, John H, Chen, Sharon C
Publicado 2022

Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)

por Maschmeyer, Georg, De Greef, Julien, Mellinghoff, Sibylle C., Nosari, Annamaria, Thiebaut-Bertrand, Anne, Bergeron, Anne, Franquet, Tomas, Blijlevens, Nicole M. A., Maertens, Johan A.
Publicado 2019

Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients

por Gonçalves, Samuel M., Lagrou, Katrien, Rodrigues, Cláudia S., Campos, Cláudia F., Bernal-Martínez, Leticia, Rodrigues, Fernando, Silvestre, Ricardo, Alcazar-Fuoli, Laura, Maertens, Johan A., Cunha, Cristina, Carvalho, Agostinho
Publicado 2017

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis

por Maertens, Johan A., Rahav, Galia, Lee, Dong-Gun, Haider, Shariq, Ramirez-Sanchez, Isabel Cristina, Klimko, Nikolai, Ponce-de-León, Alfredo, Han, Seongah, Wrishko, Rebecca, Winchell, Gregory A., Grandhi, Anjana, Waskin, Hetty
Publicado 2023

The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial

por Schoemans, Helene M., Goris, Kathy, Van Durm, Raf, Fieuws, Steffen, De Geest, Sabina, Pavletic, Steven Z., Im, Annie, Wolff, Daniel, Lee, Stephanie J., Greinix, Hildegard, Duarte, Rafael F., Poiré, Xavier, Selleslag, Dominik, Lewalle, Philippe, Kerre, Tessa, Graux, Carlos, Baron, Frédéric, Maertens, Johan A., Dobbels, Fabienne
Publicado 2018

When to change treatment of acute invasive aspergillosis: an expert viewpoint

por Slavin, Monica A, Chen, Yee-Chun, Cordonnier, Catherine, Cornely, Oliver A, Cuenca-Estrella, Manuel, Donnelly, J Peter, Groll, Andreas H, Lortholary, Olivier, Marty, Francisco M, Nucci, Marcio, Rex, John H, Rijnders, Bart J A, Thompson, George R, Verweij, Paul E, White, P Lewis, Hargreaves, Ruth, Harvey, Emma, Maertens, Johan A
Publicado 2021

Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Tra...

por Spanjaart, Anne Mea, Ljungman, Per, De La Camara, Rafael, Tridello, Gloria, Ortiz-Maldonado, Valentín, Urbano-Ispizua, Alvaro, Barba, Pere, Kwon, Mi, Caballero, Dolores, Sesques, Pierre, Bachy, Emmanuel, Di Blasi, Roberta, Thieblemont, Catherine, Calkoen, Friso, Mutsaers, Pim G.N.J., Maertens, Johan A., Giannoni, Livia, Nicholson, Emma, Collin, Matthew P., Vaz, Carlos Pinho, Metafuni, Elisabetta, Martínez-López, Joaquín, Dignan, Fiona, Ribera, Josep-Maria, Nagler, Arnon, Folber, František, Sanderson, Robin, Bloor, Adrian, Ciceri, Fabio, Knelange, Nina, Ayuk, Francis A., Kröger, Nicolaus, Kersten, Marie José, Mielke, Stephan
Publicado 2021

Prospective validation of the prognostic relevance of CD34(+)CD38(–) AML stem cell frequency in the HOVON-SAKK132 trial

por Ngai, Lok Lam, Hanekamp, Diana, Janssen, Fleur, Carbaat-Ham, Jannemieke, Hofland, Maaike A. M. A., Fayed, Mona M. H. E, Kelder, Angèle, Oudshoorn-van Marsbergen, Laura, Scholten, Willemijn J., Snel, Alexander N., Bachas, Costa, Tettero, Jesse M., Breems, Dimitri A., Fischer, Thomas, Gjertsen, Bjørn T., Griškevičius, Laimonas, Juliusson, Gunnar, van de Loosdrecht, Arjan A., Maertens, Johan A., Manz, Markus G., Pabst, Thomas, Passweg, Jakob R., Porkka, Kimmo, Valk, Peter J. M., Gradowska, Patrycja, Löwenberg, Bob, de Leeuw, David C., Janssen, Jeroen J. W. M., Ossenkoppele, Gert J., Cloos, Jacqueline
Publicado 2023

Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial

por Rijneveld, Anita W., van der Holt, Bronno, de Weerdt, Okke, Biemond, Bart J., van de Loosdrecht, Arjen A., van der Wagen, Lotte E., Bellido, Mar, van Gelder, Michel, van der Velden, Walter J. F. M., Selleslag, Dominik, van Lammeren-Venema, Daniëlle, Halkes, Constantijn J. M., Fijnheer, Rob, Havelange, Violaine, van Sluis, Geerte L., Legdeur, Marie-Cecile, Deeren, Dries, Gadisseur, Alain, Sinnige, Harm A. M., Breems, Dimitri A., Jaspers, Aurélie, Legrand, Ollivier, Terpstra, Wim E., Boersma, Rinske S., Mazure, Dominiek, Triffet, Agnes, Tick, Lidwine W., Beel, Karolien, Maertens, Johan A., Beverloo, H. Berna, Bakkus, Marleen, Homburg, Christa H. E., de Haas, Valerie, van der Velden, Vincent H. J., Cornelissen, Jan J.
Publicado 2022